Therefore, ground on GSE14520 and GSE76427 datasets, ICGC and TCGA databases, and TISIDB and TIMER databases, the correlation between NAP1L1 and immune cells was analyzed by applying HCC patients. Here, NAP1L1 is linked to hepatocellular carcinoma.